Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

This could lead to the development of precision allergy treatments that are fast acting, needle free, and tailored to individual allergen sensitivities.